NEULAND LABORATORIES LTD. SHARE PRICE [LIVE]

BSE: INE794A01010   NSE: NEULANDLAB   SECTOR: Pharma

OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
1,115.20
Change:
BSE
1,116.70
Change:
NSE
BSE Click here to view BSE data
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality
Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Sector
Sensex
Name Mar 21 Dec 20

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in NEULAND LABORATORIES LTD.

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

NEULANDLAB News

Frequently Asked Questions

What is the Share price of NEULAND LABORATORIES LTD. (NEULANDLAB)?

NEULAND LABORATORIES LTD. (NEULANDLAB) share price as of August 19, 2022, on NSE is Rs 1,115.20 (NSE) and Rs 1,116.70 (BSE) on BSE.

Can I buy NEULAND LABORATORIES LTD. (NEULANDLAB) shares?

Yes, You can buy NEULAND LABORATORIES LTD. (NEULANDLAB) shares by opening a Demat account with Angel One.

How do I buy NEULAND LABORATORIES LTD. (NEULANDLAB) from Angel One?

NEULAND LABORATORIES LTD. (NEULANDLAB) share can be brought through the following modes:
  1. Direct investment: You can buy NEULAND LABORATORIES LTD. (NEULANDLAB) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to NEULAND LABORATORIES LTD. (NEULANDLAB) shares.

In which sector do NEULAND LABORATORIES LTD. (NEULANDLAB) belong?

NEULAND LABORATORIES LTD. (NEULANDLAB) belongs to Pharma.

About NEULANDLAB

Today's live share price for NEULAND LABORATORIES LTD. is NSE: ₹ 1,115.20, BSE: ₹ 1,116.70 with a current market capitalization of .

Set up in 1984 as a private limited company to manufacture bulk drugs, Neuland Laboratories (NLL) is promoted by D R Rao. Neuland Drugs & Pharmaceuticals Pvt Ltd, a company set up by the same promoters to manufacture bulk drugs was merged with NLL with effect from Apr.'92. NLL manufactures bulk drugs such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin. It came out with its initial public offering in Apr.'94 at a premium of Rs 35 aggregating Rs 5.69 cr, to part-finance the capacity expansion to manufacture bulk drugs and to diversify its product-mix. The cost of the project as estimated by ICICI was Rs 15.7 cr. NLL's products are exported to more than 35 countries including Germany, Italy, Switzerland, the UK and the Netherlands. The company is also negotiating with multinational companies for tying up supplies of Ranitidine Hydrochloride Form I and Salbutamol Sulphate. During the year 1999-2000, the company introduced Itraconazole, an anti-fungal drug and Ipratropium Bromide, an anti-asthmatic drug and the R & D has developed a process for manufacture of Oflaxacin for Regulatory Markets. The Pashamylaram unit has received USFDA approval for manufacturing of Rantidine Hydrochloride Form. Mirtrazapine, an anti-depressive drug and Ramipril a cardiovascular drug were introduced during the year 2001.The installed capacities of Ciprofloxacin and Ranitidine were increased with Rs.650 lacs financial assisitance from IDBI. The company is closely working with several companies in Europe and North America for supply of active pharmaceutical ingredients and intermediates.

Read more